SHMT2 and nonpapillary renal cell carcinoma: To investigate the aberrant expression of SHMT2, we first analyzed the mRNA and protein expression levels in 12 pairs of ccRCC specimens using qRT-PCR (Fig. 1B) and western blot (Fig. 1C), respectively, which showed that SHMT2 was markedly upregulated in ccRCC tissues.